FDA Inspection
MedImmune U.K. LimitedMedImmune U.K. Limited – FDA Inspection, Jun 8, 2018
Record Details
This FDA Inspection record concerns MedImmune U.K. Limited, with an inspection on June 8, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Person
- Omotunde O. Osunsanmi (Issuing Officer)
View Company Profile
ID · b11fb191-da54-4f46-a09b-d2e5a19dbad4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1059831
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of MedImmune U.K. Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 15, 2024 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 14, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 17, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 13, 2015 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for MedImmune U.K. Limited
- FDA Inspection 1258494 - 2024-05-16
- FDA Inspection 1232941 - 2024-03-15
- FDA Inspection 1175803 - 2022-06-14
- FDA Inspection 1007257 - 2017-02-17
- FDA Inspection 928280 - 2015-05-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.